Submitted by Alberto on Tue, 05/30/2017 - 14:14
CB1 is the main cannabinoid receptor in the brain but is also found in other tissues. CB1 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently reduces cAMP upon activation. This in turn regulates many second messenger pathways.
Submitted by Alberto on Mon, 03/14/2016 - 13:14
CBG is a non-psychoactive cannabinoid with therapeutic potential in cancer, neurodegenerative diseases, anorexia and cachexia , gastrointestinal inflammation, glaucoma, Psoriasis, chronic
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
Huntington's disease is a genetic neurodegenerative disorder, marked by preferential degeneration of neurons in the basal ganglia (caudate and putamen) and accompanied by motor deficits, cognitive impairment and psychiatric symptoms.
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
COPD is a chronic lung disease. To date, no cure exists for COPD and therefore most treatments focus on reducing symptoms and suppressing discomfort.
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
OCD is an anxiety disorder characterised by the obsessive urge for repetitive behaviour.
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
Psoriasis is an auto-immune disease characterized by itchy skin lesions. Psoriasis arises when the immune system mistakenly identifies skin cells as foreign matter and causes over-production of new skin cells.
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
cannabinoids have excellent therapeutic potential for the treatment of epilepsy. In the brain, the endocannabinoid system tends to keep neuronal activity wihtin acceptable boundaries.
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
Submitted by heiko@ghsctradi... on Mon, 03/14/2016 - 13:14
TRPV3 is one of the non-GPCR-coupled cannabinoid receptors. TRPs are typically involved in pain sensation.